Market Overview:
The global point of care molecular diagnostics market size reached US$ 2.98 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.65 Billion by 2027, exhibiting a growth rate (CAGR) of 10.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Point-of-care (POC) molecular diagnostics refer to tests performed by physicians to diagnose and detect infectious diseases. It includes hematology, pregnancy, fertility, infectious diseases, urinalysis testing kits, and cardiometabolic and glucose monitoring devices. POC molecular diagnostics is widely used for identifying infectious agents, minimal residual disease, and gastrointestinal disorders, monitoring hemoglobin and fecal occult blood, and determining a patient's ability to metabolize a drug or drug class. These tests offer faster results, reduce complications associated with mistreatment, and improve infection control measures. As a result, POC molecular diagnostics finds extensive applications in hospitals, intensive care units (ICUs), research institutes, clinics, decentralized laboratories, and homecare facilities.
Point of Care Molecular Diagnostics Market Trends:
The increasing prevalence of infectious diseases across the globe is creating a positive outlook for the market. POC molecular diagnostic tests is a cost-effective solution widely used to manage infectious diseases, such as flu, tuberculosis, human immunodeficiency virus (HIV) infection, chlamydia, and hepatitis. Additionally, the rising demand for PCR test kits to effectively manage and control the spread of COVID-19 is acting as another growth-inducing factor. Furthermore, the adoption of miniaturization, nanotechnology, and microfluidics to develop low-cost, user-friendly, and highly sensitive molecular diagnostic tests is providing an impetus to the market growth. Moreover, the implementation of various government initiatives toward improving healthcare infrastructure and enhancing molecular diagnostic capabilities is positively influencing the market growth. Other factors, including rapid advancements in deoxyribonucleic acid (DNA) sequencing, rising awareness regarding advanced therapeutic and diagnostic tests, increasing geriatric population, and recent developments in cloud-connected POC diagnostic technologies, are anticipated to drive the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global point of care molecular diagnostics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product and service, technology, application and end user.
Breakup by Product and Service:
- Assays and Kits
- Instruments and Analyzers
- Software and Services
Breakup by Technology:
- Polymerase Chain Reaction (PCR)
- Hybridization
- DNA sequencing
- Microarray
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Others
Breakup by Application:
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Others
Breakup by End User:
- Physicians’ Offices
- Hospitals and ICUs
- Research Institutes
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Binx Health Inc., Co-Diagnostics Inc., F. Hoffmann-La Roche Ltd, Gene STAT Molecular Diagnostics LLC, Hemocue AB (Danaher Corporation), Meridian Bioscience Inc., Molbio Diagnostics Private Limited, Quidel Corporation, Siemens Healthcare GmbH (Siemens AG), Thermo Fisher Scientific Inc. and Visby Medical Inc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Product and Service, Technology, Application, End User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Abbott Laboratories, Becton Dickinson and Company, Binx Health Inc., Co-Diagnostics Inc., F. Hoffmann-La Roche Ltd, Gene STAT Molecular Diagnostics LLC, Hemocue AB (Danaher Corporation), Meridian Bioscience Inc., Molbio Diagnostics Private Limited, Quidel Corporation, Siemens Healthcare GmbH (Siemens AG), Thermo Fisher Scientific Inc. and Visby Medical Inc. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global point of care molecular diagnostics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global point of care molecular diagnostics market?
- What are the key regional markets?
- What is the breakup of the market based on the product and service?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global point of care molecular diagnostics market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Point of Care Molecular Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product and Service
6.1 Assays and kits
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments and Analyzers
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Software and Services
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Technology
7.1 Polymerase Chain Reaction (PCR)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Hybridization
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 DNA sequencing
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Microarray
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Application
8.1 Infectious Diseases
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Oncology
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Hematology
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Prenatal Testing
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Endocrinology
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by End User
9.1 Physicians’ Offices
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospitals and ICUs
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Research Institutes
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Becton Dickinson and Company
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Binx Health Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Co-Diagnostics Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 F. Hoffmann-La Roche Ltd
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.6 Gene STAT Molecular Diagnostics LLC
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Hemocue AB (Danaher Corporation)
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Meridian Bioscience Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Molbio Diagnostics Private Limited
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Quidel Corporation
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Siemens Healthcare GmbH (Siemens AG)
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Thermo Fisher Scientific Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13 Visby Medical Inc.
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
List of Figures
Figure 1: Global: Point of Care Molecular Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Point of Care Molecular Diagnostics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Point of Care Molecular Diagnostics Market: Breakup by Product and Service (in %), 2021
Figure 5: Global: Point of Care Molecular Diagnostics Market: Breakup by Technology (in %), 2021
Figure 6: Global: Point of Care Molecular Diagnostics Market: Breakup by Application (in %), 2021
Figure 7: Global: Point of Care Molecular Diagnostics Market: Breakup by End User (in %), 2021
Figure 8: Global: Point of Care Molecular Diagnostics Market: Breakup by Region (in %), 2021
Figure 9: Global: Point of Care Molecular Diagnostics (Assays and Kits) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Point of Care Molecular Diagnostics (Assays and Kits) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Point of Care Molecular Diagnostics (Instruments and Analyzers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Point of Care Molecular Diagnostics (Instruments and Analyzers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Point of Care Molecular Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Point of Care Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Point of Care Molecular Diagnostics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Point of Care Molecular Diagnostics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Point of Care Molecular Diagnostics (Hybridization) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Point of Care Molecular Diagnostics (Hybridization) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Point of Care Molecular Diagnostics (DNA sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Point of Care Molecular Diagnostics (DNA sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Point of Care Molecular Diagnostics (Microarray) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Point of Care Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Point of Care Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Point of Care Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Point of Care Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Point of Care Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Point of Care Molecular Diagnostics (Infectious Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Point of Care Molecular Diagnostics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Point of Care Molecular Diagnostics (Oncology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Point of Care Molecular Diagnostics (Oncology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Point of Care Molecular Diagnostics (Hematology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Point of Care Molecular Diagnostics (Hematology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Point of Care Molecular Diagnostics (Prenatal Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Point of Care Molecular Diagnostics (Prenatal Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Point of Care Molecular Diagnostics (Endocrinology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Point of Care Molecular Diagnostics (Endocrinology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Point of Care Molecular Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Point of Care Molecular Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Point of Care Molecular Diagnostics (Physicians’ Offices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Point of Care Molecular Diagnostics (Physicians’ Offices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Point of Care Molecular Diagnostics (Hospitals and ICUs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Point of Care Molecular Diagnostics (Hospitals and ICUs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Global: Point of Care Molecular Diagnostics (Research Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Global: Point of Care Molecular Diagnostics (Research Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Global: Point of Care Molecular Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Global: Point of Care Molecular Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: North America: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: North America: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: United States: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: United States: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Canada: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Canada: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Asia-Pacific: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Asia-Pacific: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: China: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: China: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Japan: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Japan: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: India: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: India: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: South Korea: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: South Korea: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Australia: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Australia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Indonesia: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Indonesia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Europe: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Europe: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Germany: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Germany: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: France: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: France: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: United Kingdom: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: United Kingdom: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Italy: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Italy: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Spain: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Spain: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Russia: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Russia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Latin America: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Latin America: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Brazil: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Brazil: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Mexico: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Mexico: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 91: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 92: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 93: Middle East and Africa: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 94: Middle East and Africa: Point of Care Molecular Diagnostics Market: Breakup by Country (in %), 2021
Figure 95: Middle East and Africa: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 96: Global: Point of Care Molecular Diagnostics Industry: SWOT Analysis
Figure 97: Global: Point of Care Molecular Diagnostics Industry: Value Chain Analysis
Figure 98: Global: Point of Care Molecular Diagnostics Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Point of Care Molecular Diagnostics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Product and Service (in Million US$), 2022-2027
Table 3: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 4: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Point of Care Molecular Diagnostics Market: Competitive Structure
Table 8: Global: Point of Care Molecular Diagnostics Market: Key Players